Retatrutide Doubles Weight Loss But Needle Waste Piles Up
💡 Why it matters
The dual challenge of effective obesity treatment and safe disposal of medical waste could strain public health systems and recycling infrastructure.
Eli Lilly's retatrutide shows double the weight loss of Ozempic in a head-to-head trial, while recycling facilities report a surge in discarded needles from weight-loss injections.
Want more context?
Help us choose what to research next.
📡 Where we spotted it (4)
abcnews.com
New weight loss drug retatrutide provides double the weight loss of Ozempic, data shows
14h ago
›
yahoo.com
Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles weight loss
14h ago
›
investor.lilly.com
Lilly's retatrutide delivered greater A1C reduction and more than double the weight loss of Ozempic's highest approved dose in head-to-head trial
14h ago
›
BBC News
Weight-loss jab boom brings needles warning for recyclers
2h ago
›